Skip to main content
OpenTrials

Clinical trial condition

Colorectal Cancer

Explore clinical trials studying Colorectal Cancer. Study availability and eligibility vary by location and protocol.

2,501 public trials 464 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Cancer trial results

Recruiting

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

NCT06445062

Conditions
Adenocarcinoma, CRC, Carcinoma, +25 more
Locations
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 32 locations
View Trial Details
Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions
Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations
  • City of Hope Duarte, California, United States
  • UC IRVINE Health Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 56 locations
View Trial Details
Recruiting

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

NCT07227636

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +11 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

NCT07750158

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists - Council Bluffs Council Bluffs, Iowa, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island Grand Island, Nebraska, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional Grand Island, Nebraska, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist Omaha, Nebraska, United States
View all 13 locations
View Trial Details

Related conditions